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Abstract
Obsessive-compulsive disorder is a behavior disorder
characterized by recurrent.

intense thoughts and repetitive.

ritualistic acts. Treatments for obsessive compulsive disorder
typically consist of either exposure and response prevention or
pharmacotherapy. particularly benzodiazepines.

Combinations of

these two types of treatment could lead to three possible
outcomes.

First.

the combination of exposure and response

prevention and benzodiazepines may show no better results than
exposure and response prevention alone.

Second. combination

therapy may result in a better effect than exposure and response
prevention alone--the drug will decrease anxiety during exposure
without increasing the relapse rate after treatment.

Third.

combination therapy could have worse effects than exposure and
response prevention alone by increasing the rate of relapse
through state-dependent learning--Iearning occurring during the
drugged state does not transfer to the non-drugged state.

The

purpose of this study was to assess the effects of the
combination of exposure and response prevention with the
benzodiazepine alprazolam using a single-subject design. This
design alternated between exposure and response prevention plus
alprazolam and exposure and response prevention alone.

The

results of this study show that the alprazolam condition did not
differ from the placebo condition. suggesting that alprazolam did
not function effectively to reduce the subject's anxiety.

Obsessive-Compulsive Disorder

3

A Pilot Study on the Use of Alprazolam-Assisted Exposure and
Response Prevention in Obsessive-Compulsive Disorder

Obsessive compulsive disorder (OCD) has a lifetime
prevalence of 2-3% (Robins, Helzer.

&

Weissman.

estimate is much higher than previous estimates,

This

1984).

indicating that

OCD is almost three times more prevalent than schizophrenia
(Greist.

1990a).

As such a

common disorder.

note that until the last decade, most
been largely ineffective (Jenfke.

it is surprising to

treatments for OCD have

1983).

OCD treatment was

greatly advanced with the introduction of the behavioral
technique exposure and response prevention (Boersma. Den Hengst,
Dekker, & Emmelkamp.

1976; Perse.

1988; G-reist,

1990a,

1990b) and

various pharmacotherapy techniques, most notably clomipramine
(Greist, et a1..

1990; Trimble.

1990).

Unfortunately. not all

obsessive compulsives benefit from either of these two
treatments; further research is warranted to discover a treatment
method that will help all OCD patients.
Obsessive compulsive disorder affects men and women
approximately equally (Jenike.

1983; Rasmussen & Tsuang,

1984)

with 60-65% of patients exhibiting an onset of the disorder
before age 25 (Jenike,
1984).

1983; Perse.

1988; Rasmussen & Tsuang.

In about 60% of OCD cases. an identifiable precipitant

has been noted;

the most common of these precipitants are

pregnancy and childbirth, sexual components. and death of a loved
one.

Although the course of the disorder was previously viewed

•
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as chronic and deteriorating, most patients exhibit a course that
IS

episodic with periods of remission that are not complete but
allow for normal social functioning (Rasmussen & Tsuang,

that
1984).

According to the Diagnostic and Statistical Manual Third
Edition Revised (American Psychiatric Association.

1987),

obsessive compulsive disorder is defined by the presence of
recurrent, persistent thoughts or ideas. called obsessions. and
by repetitive, ritualistic compulsions--acts that the person
feels compelled to do, generafly in response to the obsession.
1'he person will perform the compulsion in an attempt to reduce
the anxiety brought about by the obsession. but this relief is
short-lived.

Most people with this disorder have both obsessions

and compulsions. and the DSM-IIIR states that the person must be
aware that his/her behaviors and thoughts are unrealistic and ego
dystonic (American Psychiatric Association.

1987).

The most common types of obsessions are those that center
around the fear of contamination (Rasmussen & Eisen.

1989).

Understandably. the compulsion that accompanies this fear is
washing.

Patients will spend hours out of their day excessively

washing their hands and bodies, their clothes. and their homes to
remove the toxins and dirt that they believe could potentially
harm themselves or their families.
checking and counting.

Other common compulsions are

A patient who fears that she may have

forgotten to lock the door when she left home will return to her
home dozens of times to check the lock.

Another patient may

•
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count to a certain number in his head every time he has an
obsession.
Exposure and response prevention in the treatment of
obsessive compulsive disorder has been shown to have success
ratcs of up to

80~

(of patients showing marked improvement of

symptoms) when the patients comply with the program (Perse.
1988).

Exposure and response prevention are often preferred over

the pharmacological treatment clomipramine. a serotonin re-uptake
inhibiting medication which has recently been approved for the
treatment of OCD.

Approximatily 24% of patients relapse after

exposure and response prevention (Greist.

1990b), while

approximately 90% of patients relapse after the discontinuation
of clomipramine (Greist. et al.,

1990).

.Further, a number of

patients are unable to tolerate the large side effect profile
which accompanies the use of clomipramine (Trimble.

1990:

Tollefson. 1985).
Exposure and response prevention can be assisted by a
therapist or can be done by the patient alone (possibly as a
homework assignment given by the therapist).

Exposure can be

conducted either in vivo, where the patient actually comes into
contact with the feared stimulus. or in imagination when the
stimulus is too frightening or dangerous.
stimulus is continued until

Exposure to each

the patient"s anxiety has decreased

substantially.

Greist (1990a) recommends that an exposure

session last at

least JO-45 minutes. but

necessary for anxiety to decrease.

longer sessions may be

Response prevention requires
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the patient to refrain from the anxiety-reducing compulsion for
increasingly longer periods of time.
As noted above, exposure and response prevention is the
treatment of choice for some researchers and therapists because
of its high success rates

dUel

low rates of relapse.

However, up

to 25% of patients will not comply with the anxiety-provoking,
rigorous treatment style of the behavior therapy (Greist,

1990a).

In order to reduce the anxiety brought about by behavior therapy,
some researchers have proposed the combination of
benzodiazepines and exposure and response prevention (Kamano,
1972; Marks and Swinson,
Gardner,
outcomes.

1972).

1990: Marks, Viswanathan. Lipsedge, &

This combination could lead to three possible

First. the combination may yield no better effect than

behavior therapy alone;

in which case.

would be of no clinical value.

the combination therapy

Second. the combination may

facilitate exposure and response prevention by generating higher
success rates than behavior therapy alone.

If this is the case,

the combination therapy would be of great clinical value-
patients would not experience intense discomfort during the
treatment. and thus, more patients would comply with the therapy.
Further. with higher success rates, more patients would be
helped.

The last possible outcome of the combination therapy is

the occurrence of state-dependent learning.

State-dependent

learning is the phenomenon in which learning that takes place
while under the influence of a drug, such as alcohol. does not
transfer to the non-drugged state.

Thus,

learning is dependent
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State-dependent

learning is very detrimental because it results in high rates of
relapse after treatment and requires a re-Iearning of the
information previously learned while in the drugged state.
Several studies have been conducted to investigate statedependent learning.

Patel, Ciofalo. and Iorio (1979) found that

mice administered one of four benzodiazepines before the training
of a passive-avoidance task did not exhibit the avoidance task in
the next day's non-drugged training session.

Similarly, Bouton,

Kenney, and Rosengard (1990) found the acquisition of fear
extinction in benzodiazepine-drugged mice to be state-dependent.
The authors suggest that if state-dependent learning occurs in
humans undergoing combination therapy relapse rates will be quite
high after the drug is discontinued.
A few studies on the effects of combined treatment in humans
have been conducted and have found quite different results from
the previously mentioned studies.

Wardle (1990) reviewed six

studies in which exposure plus an anxiolytic was compared to
exposure plus placebo in the treatment of phobics.

In all but

one of these trials, acute benzodiazepine treatment was employed;
this means that the drug was given either during or before the
exposure sessions, never between the sessions.

Wardle found that

four of the six trials had better results with the combined
treatment.
Another study by Marks et al.

(1972) performed using

diazepam suggested that the drug most facilitated behavior
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therapy with phobics when the drug was administered so that its
effect was decreasing during the exposure sessions.

I tis

hypothesized that state-dependent learning is more likely to
occur when the drug is having its peak effect than when the
drug's effects arc waning.

Neither of these studies reported

patient relapse when the drug was discontinued.
The above research was conducted using the drug diazepam,
but one study (Marks & Swinson,

1990) was carried out combining

the benzodiazepine alprazolam and behavior therapy in the
treatment of agoraphobics. with much different results.

The

subjects in this study were placed on alprazolam for eight weeks,
with an average final dose of 5 rug/day.

After the drug was

discontinued, a high number of the subjects relapsed, suggesting
that state-dependent learning occurred.
Wardle (1990) and Marks et al.

However,

the studies by

(1972) suggest that the manner in

which alprazolam was employed in this study may actually have
created a conducive environment for relapse.

For example, the

trials reviewed by Wardle (1990) and Marks et al.

(1972)

incorporated acute benzodiazepine treatment and found evidence
for the efficacy of combined treatment, while Marks and Swinson
(1990) used continuous benzodiazepine treatment and found a high

relapse rate.

Unless other research is performed to study the

effects of alpruzolam assisted exposure and response prevention,
incorporating the use of alprazolam in the manner implicated by
Wardle (1990) and Marks eL dl.
combination may go undiscovered.

19721.

Lhc efficacy of that

..
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One such study was conducted by Bruce, Spiegal, and McGrath
(1993) to examine the effects of alprazo]am-assisted exposure and
response prevention in a social phobic.

This study consisted of

six units of exposure to six different tasks, with three units
employing a placebo pill and the other three employing 0.5 mg of
alprazolam.

The results clearly showed that alprazolam

functioned effectively to reduce the subject's anxiety, but they
also indicated that some state-dependent learning may have
occurred.

The researchers found that

learning taking place

during alprazolam-assisted ex~osure did not transfer as well as
learning taking place during the placebo condition, but it was
not entirely clear whether this was the result of state-dependent
learning or of some subject-related factor.
Research on combined therapy using acute treatment of
diazepam and alprazolam suggests excellent success rates with
little or no state-dependent
phobics.

learning in the treatment of

However, no published studies on the use of combined

therapy and obsessive compulsive disorder exist.

Therefore,

the

following study is proposed to test the efficacy of combined
therapy on OCD.

Following the previous research on acute

benzodiazepine treatment

in phobics,

it is predicted that

combining the short-acting benzodiazepine, alprazolam, and
exposure and response prevention in obsessive compulsi.ve disorder
will facilitate the behavior therapy without resulting in the
occurrence of state-dependent

learning.

If the prediction is

upheld by the results of this study, further research in this

•

Obsessive-Compulsive Disorder 10
area will be warranted to determine if combined treatment for
obsessive compulsive disorder may be superior to exposure and
response prevention alone.
Method
Subject
The subject was a fifteen year old male with a primary DSM
IIIR Axis I diagnosis of obsessive-compulsive disorder.

His

disorder centered around his obsessions of contamination.

The

subject's method of coping with the contamination was through
excessive washing.

His score on the Yale-Brown Obsessive

Compulsive Scale (Y-BOCS) was 33, which indicated a severe,
although self-reported,

level of OCD.

The subject had been on no

medications for his disorder and had not participated in any
other form of treatment for it.

He came to the University of

Illinois College of Medicine at Peoria in 1993 for the treatment
of his disorder and agreed to participate in this study.
Appar a t us _illLd--.Ma t e rj a I.§.
The subject was monitored using the Vitalog 5000--a portable
device designed to measure heart rate and to maintain a
computerized account of all data.

(Kozak, Foa, & Steketee (1988)

showed that heart rate measures are highly correlated with
anxiety).

Further . .subjective ratings of anxiety (Subjective

Units of Distress or SUDS) and the urge to wash were taken
approximately every five minutes during each 60 minute therapistdirected exposure session.
scale.

These ratings were taken on a 0-100

Finally, before each session the subject was asked La
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report

(on a 0-100 scale) his anticipatory anxiety, his

confidence level. and his belief that doing the upcoming exposure
task would make the next exposure task easier.

He was also asked

to estimate his current heart rate and his maximum heart rate
during the upcoming exposure.
to report

After each session. he was asked

(on a 0-100 scale) his concentration level during the

previous exposure task,

the degree to which he was distracted

during the task, his feeling of success for the task, his
confidence level for future tasks, his belief that having done
the task would make the next task easier, and his current
anxiety. contamination level. and urge to wash.

He was also

asked to estimate his maximum heart rate during the previous
exposure task.

Finally, at

the end of each day,

the subject was

asked to report whether he believed that he was given the
alprazolam.

If the subject was able to correctly report this,

this confounding variable would have to be taken into
consideration during data analysis.
Procedur~

This study ran for 12 consecutive days, during which time,
the subject was exposed to a series of four tasks.

Exposure to

each of tile four tasks occurred in the natural environment,
either at the clinic. the subject's home.

OT

a local hospital.

Each series required three days to complete--an active day. a
washout day, and a state-dependent day.

The active days

consisted of four GO-minute exposure sessions. while the statedependent day consisted of three.

No exposure sessions occurred
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on the washout day.

Once each series was complete. a new series

of exposures began. utilizing a task which was about equal to the
first

in the amount of anxiety that was provoked.

continued until four series had been completed.

This cycle
The response

prevention rules across the entire sequence were identical.

The

subject was not allowed to wash during the exposure session or
before eating or to change his clothes during the day.
On the morning of the first day.

the subject was

familiarized with the Vitalog 5000 and to the subjective measures
which were used during the

ex~osure

sessions.

Once the

orientation was complete, the series of exposure sessions began.
On the first day, which was called the active day.

the

subject was given a baseline exposure task (Task A), such as
placing his hand on a contaminated doorknob.
session, including the baseline task.

Each exposure

lasted for 60 minutes.

The

baseline task allowed for the measurement of the initial values
of the heart rate, anxiety. and urge to wash while the subject
was in the non-drug state.
After the baseline task. the subject was given a glass of
orange juice which contained either 0.5 mg of alprazolam or no
drug at all.

The determination of 0.5 mg follows the study by

Bruce, Spiegal, and McGrath (1993) and is suggested by Gitlin
(1990) as the optimal starting dose for the treatment of acute or
situational anxiety.

The administration of the drug or the

placebo was conducted In a double-blind fashion.
person determined

011

An independent

which two active days the drug would be

•
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present and on which two the placebo would be present through a
random lottery procedure.

This person also prepared the drugged

or non-drugged juice to insure blindness on the part of the
therapists.

To insure that the subject was completely unaware of

when he was receiving the drug, a glass of non-drugged orange
juice was given before each baseline task and before and after
each post-drug exposure session.
Beginning roughly one hour later, Task A was repeated. with
three more 60-minute exposure sessions occurring.

On the days

when alprazolam was ingested, this time lapse allowed alprazolam
to be at its peak of action during the first post-drug exposure
session and gradually decreasing in effect over the next two.
On the second day. called the washout day. the subject did
not visit the therapist and was instructed not to practice the
exposure techniques that he had learned.

For the active days in

which alprazolam was received, the washout day allowed time for
most of the drug to be removed from the blood stream.
The third day was called the state-dependent day.

On this

day. the schedule followed quite closely with that of the active
day.

Orange juice was still given at the same times as the

active day (to insure the subjecl was blind to the administration
of the drug), except that no drug was ever given on statedependent day.

Task A was repeated, but only three 60 minute

exposure sessions were given.

Additionally,

if the subjective

ratings were less than or equal to 10 for 5 consecutive ratings
(or 20 minutes).

the session was terminated.

•
Obsessive-Compulsive Disorder 14
State-dependent day tested for the occurrence of state
dependent learning, since the drug had enough time to be removed
from the blood stream.

If the gains made during the exposure

sessions aided by alprazolam showed state dependency,

then the

objective (heart rate) and subjective (anxiety and urge to wash)
measures on this day would be near those of the active day
baseline.

If no state-dependency occurred,

the learning from the

active day's exposure sessions would be evidenced by much lower
objective and subjective measures on state-dependent day than
those of the active day baselfne.
Proposed DesiKn
This study incorporated an alternating treatments design
(ATD).

This is the design of choice in studies such as this,

because it allows the researcher to alternate between two or more
treatment conditions fairly rapidly and to easily discriminate
differences between the conditions.

The treatment design was

excellent for this study because it allowed for the determination
of whether alpruzolam effectively aided exposure and response
prevention without causing state dependent learning.
Results
When asked after the last trial of the active days and the
last trial of the state-dependent days if he believed that he had
ingested alprazolam that day,

the subject reported affirmatively

63% of the time (or five out of eight times).

Of these

affirmative reports, 40% (two out of five) were correct--he
correctly reported that he had been given the drug on two out of
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the two alprazolam-assisted active days.

When asked to rate on a

0-100 scale the degree to which his success was a result of the
drug,

the subject's average response from the two days in which

alprazolam was ingested was 25.

His average response from all

five days in which he believed he had been given the drug was
24.5.
The subject was also asked to rate himself on a number of
items before and after each exposure session.

Before each

session, the subject was asked to rate his anxiety about the
upcoming exposure task and to 'estimate his highest heart rate for
the upcoming task, and the results for both measures show an
overall decrease across trials.

He also reported his confidence

level and his belief that doing the upcoming task would make the
next task easier.
trials.

Both ratings showed an overall increase across

Finally, the subject was asked to report his current

heart rate before each task.

This measure remained virtually

unchanged across trials.
After each session. the subject was asked to rate his
concentration level and distraction level for the preceding
exposure session.

The subject's average concentration level

across trials was 70.45 (out of 100), while his average
distraction level was 19.73 (out of 100).

The subject's rating

of success for the preceding task and his ·confidence in his
ability to do future tasks showed no obvious increases or
decreases.

The subject's average rating of success across trials

was 76.43 (out of 100). while his average confidence level was
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64.46 (out of 100).

The subject also estimated his highest heart

rate for the preceding trial, and this rating showed an obvious
decline across trials, with an average rating of 87.57.

The

subject's rating that doing the previous task would make the next
task easier showed no obvious trend.

finally,

the subject's

average ratings (across trials) of his anxiety, urge to wash, and
contamination after the exposure task were all quite 10w--2.48,
4.21, and 3.57 (out of 100), respectively.
The subject's Y-BOCS scores were also of interest.

The

subject's initial Y-BOeS totar score was 33 before treatment;
this indicates a severe level of OCD.

After treatment. the
At the five month follow-up,

subject's score had decreased to 2.
the subject's score was 8.

In order to determine if a difference existed between the
alprazolam-assisted exposure sessions and the placebo exposure
sessions. all data were collapsed. and a 2 X 3 factorial design
(drug X condition) was done.

The 2 X 3 ANOVA revealed a non

significant main effect of drug,

E

(1. 31)

non-significant main effect of condition,
.01.

= 2.77,
E

(2, 31)

Q >

.01

and a

= 3.15,

Q >

figures 1 and 2 illustrate the results of this analysis-

the two graphs show very little difference between them,
suggesting that the drug did not exhibit an anxiolytic effect in
the patient.

for an anxiolytic effect to be present, a much

greater reduction in Dl (the average SUDS of the first trials
from the drug days) from baseline as compared to the placebo
condition must be evident. and it

IS

not.
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Sl (the average SUDS of trials one from the state dependent
days following alprazolam ingestion) showed no rebounding effect,
the major test for the occurrence of state-dependent learning
(See Figure ll.

If state-dependent learning hud occurred,

it

would have been evidenced by mean SUDS scores on Sl approximately
equal to those of the active day baseline.

Insert Figures 1 and 2 about here

'.

Since similar trends were faund in the urge to wash,
graphs are not included.
heart rate data.

these

Also not included is the objective

It was hoped that this data could be used to

verify the subjective ratings of anxiety ..

Unfortunately,

the

Vitalog-SOOO. which is a portable device designed to monitor
heart rate, malfunctioned early in the study, and thus,

the

desired objective data could not be obtained.
Discussion
Based on the results of this study,

the hypothesis that

combining the short-acting benzodiazepine alprazolam with
exposure and response prevention would facilitate the behavior
therapy without resulting in the occurrence of state-dependent
learning was not upheld.

No significant differences in the SUDS

scores between the alprazolam-assisted exposure sessions and the
placebo exposure sessions existed, suggesting that alprazolam did
not function effectively to reduce the subject's anxiety.
mean SUDS scores on the state-dependent day following the

The
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alprazolam-assisted act lve day showed no rebounding towards the
active day baseline.

This indicates that state-dependent

learning did not occur.
effect on the patient,
learning did not occur.

Since the drug showed no anxiolytic
it is not surprising that state-dependent
Thus.

the combination therapy showed no

better effect than exposure and response prevention alone.
The most probable explanation of these results is that the
dose of the drug was not high enough to result
reducing effect in the subject.
unusual

In addition,

in an anxiety
the subject was

in that OCD patients ienerally do not exhibit such

immediate. marked. and generalizing relief in their symptoms as
occurred with this subject.

Also.

the subject was young.

had the

disorder for only a short time. and had an unusually high initial
Y-HOCS score.

Taken together,

these facts indicate that the

results of this study arc not generalizable.

More research in

the area is necessary to obtain more generalizable results and
thus. better knowledge about the hypothesis.
Before concluding. a discussion of the internal and external
validity of the study is necessary.

The internal validity of the

study is strong in that the tests administered to the subject
(namely, the SUDS, the urge to wash. and the Y-BOeS) have been
used in a number of studies and have been shown to be valid.

The

major threat to internal validity is that the experiment was not
conducted in a tightly-controlled laboratory setting.

Instead,

the exposure sessions took place in the natural environment (i.e.
in the clinic.

in the patient's horne, and at a local hospital),
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possibly allowing for the influence of extraneous variables.
Although this impinges on the

internal validity of the study,

strengthens the generality of the findings and thus.
validity.

it

the external

The main threat to external validity is the use of the

single subject design. because the subject chosen was not
entirely representative of all

oeD

patients.

However, since the

experiment was meant only as a first-phase pilot study to
indicate the necessity of future studies in the area,
seems appropriate.

the design

Overall, the study provides a good balance

between internal and external 'validity by incorporating
standardized testing scales and a naturalistic environment for
exposure.
Although the hypothesis was not upheld by the results of
this study, future studies in the area are necessary to determine
if combined treatment for obsessive-compulsive disorder (as well
as other anxiety disorders)

is a viable alternative to exposure

and response prevention alone.

Future studies must employ more

that one subject as well as subjects of differing ages,
histories, and

oeD

severities.

treatment

It might also be necessary to

experiment with varying doses of the drug and the times at which
the drug is administered.

Hopefully, such experiments wi 11

discover a method of combining benzodiazepines such as alprazolam
with exposure and response prevention which will effectively
alleviate the subject's anxiety without resulting in the
occurrence of state-dependent learning.

Such a method would

provide relief to the many obsessive-compulsive disorder

•
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sufferers who have failed to benefit from either pharmacotherapy
nlone or exposure and response prevention alone.
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Figure Caption
Figure 1.

Mean S.U.D.S. scores as a function of trials during

the drug condition.

Each bar represents the ten minute means

from the average of the two drug conditions.
represents the standard error of the mean.

Each line
BL is the baseline,

D1-3 are the three trials of the drug days, and S1-3 are the
three trials of the state-dependent days.
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Figure Caption
Mean S.U.D.S.
the placebo condition.

~corcs

as u function of trials during

Each bar represents the ten minute means

from the average of the two placebo conditions.
represents the standard error of the mean.

Each line

BL is the baseline,

Pl-3 are the three trials of the placebo days, and Sl-3 are the
three trials of the state-dependent days.
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